Business

Amoéba receives its first order from Koppert and confirms its transformation into a commercial company

Chassieu, March 12, 2026 (GLOBE NEWSWIRE) -- Amoéba receives its first order from Koppert and confirms its transformation into a commercial company Chassieu (France), 11 March 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, announces its first order from its partner Koppert, world leader in biocontrol. Amoéba thus becomes a true commercial company, whose biocontrol activ

articleAmoeba SaMarch 12, 20264/company/amoeba-sa/news/amoeba-receives-its-first-order-from-koppert-and-confirms-its-transformation-into-a-commercial-company
Amoéba receives its first order from Koppert and confirms its transformation into a commercial company

About this update from Amoeba Sa

[{"type":"image","alt":"Amoeba","displaySize":"","headline":null,"caption":"Amoeba","className":"","disableSlideshowImg":false,"size":{"original":{"width":286,"height":176,"url":"https://media.zenfs.com/en/globenewswire.com/8f5f198b0bebaa4a2db1f0e2a68d5a4b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_bt5Mw8k_ViJJtui.mQpsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI1ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8f5f198b0bebaa4a2db1f0e2a68d5a4b","width":286,"height":176}},"lazy":false},{"type":"text","content":"Chassieu, March 12, 2026 (GLOBE NEWSWIRE) -- Amoéba receives its first order from Koppert and confirms its transformation into a commercial company","length":147,"tagName":"p"},{"type":"text","content":"Chassieu (France), 11 March 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, announces its first order from its partner Koppert, world leader in biocontrol. Amoéba thus becomes a true commercial company, whose biocontrol activities are now structured around its subsidiary Green 4 Agro, headed by Jean-Marc PETAT, former director of the Company and expert in the sector.","length":496,"tagName":"p"},{"type":"text","content":"A first order that marks a new phase in Amoéba's history","length":60,"tagName":"p"},{"type":"text","content":"The first deliveries of this order, which is part of the distribution agreement signed with Koppert in June 2025 covering vineyards and market gardens in 18 European countries and the United States, will be made in April 2026.","length":226,"tagName":"p"},{"type":"text","content":"In a context marked by accelerated regulatory developments, including requests from the agricultural sector for derogatory marketing authorisations for the use of AXPERA and the entry into the final stage for the definitive marketing authorisation of AXPERA in France1, this order will allow the company to build up the necessary stocks to meet initial demand in France, Italy and the Netherlands. Amoéba thus confirms its ability to meet the growing needs of professionals for its solutions to help them combat fungal diseases.","length":528,"tagName":"p"},{"type":"text","content":"Amoéba and Koppert therefore confirm the promising prospects of their partnership, following on from the launch of TIAGAN at the b...

More updates from Amoeba Sa

Amoébacommercial companyKoppertJean-Marc PETATUnited Statesagricultural sectorbiocontrolthe company